JohnCheretis

Associate

Washington + 1.202.879.3424

John Cheretis concentrates his practice on advising clients in complex international trade, national security, and government contracting matters. He has assisted clients with evaluating and structuring cross-border investments and supply chains, as well as navigating investigations and regulatory proceedings.

John has significant experience advising clients with respect to U.S. foreign direct investment regulations and national security considerations. John has represented clients in investment reviews conducted by the Committee on Foreign Investment in the United States (CFIUS) and in structuring transactions to mitigate CFIUS risks. He has also counseled companies in a variety of U.S. customs matters, including classification, valuation, and country of origin determinations, as well as compliance with Withhold Release Orders and other import restrictions administered by Customs and Border Protection (CBP). John has also represented clients in seeking tariff relief in proceedings before the United States Trade Representative (USTR).

John has also assisted clients with understanding and complying with various economic sanctions programs administered by the Office of Foreign Assets Control (OFAC) and export control issues arising under the Export Administration Regulations (EAR) and International Traffic in Arms Regulations (ITAR).

John maintains an active pro bono practice. He has represented U.S. veterans in obtaining disability benefits as well as individuals seeking asylum and other forms of immigration relief.

Experience

  • ARMOR USA acquires industrial segment of International Imaging Materials, Inc.Jones Day represented Armor SAS and ARMOR USA, Inc., a French-based company that specializes in the industrial formulation of inks and the coating of thin layers onto thin films, in the acquisition and financing of International Imaging Materials, Inc. ("IIMAK"), a global developer and manufacturer of value-added consumable solutions for industrial applications.
  • American Industrial Partners subsidiary Vertex Aerospace announces acquisition of Raytheon Technologies' Defense Training and Mission Critical Solutions business linesJones Day is advising American Industrial Partners in the acquisition by portfolio company, Vertex Aerospace, of Raytheon Technologies' Defense Training, Professional Services, Mission Critical Solutions, and Modernization and Sustainment business lines.
  • PPC Flexible Packaging acquires Consumer Packaging Group, LLCJones Day represented Morgan Stanley Capital Partners and its portfolio company, PPC Flexible Packaging, LLC, in PPC's acquisition and financing of the Harland, Wisconsin, based Consumer Packaging Group, LLC.
  • Sensata Technologies acquires Spear Power SystemsJones Day advised Sensata Technologies in its acquisition of Spear Power Systems, a leader in lithium-ion based energy storage solutions for mission-critical and demanding end user applications.
  • Huntington Ingalls Industries acquires Alion Science and Technology for $1.65 billionJones Day advised Huntington Ingalls Industries in the $1.65 billion acquisition of Alion Science and Technology Corporation from Veritas Capital.
  • Parker Hannifin's recommended all cash acquisition of Meggitt PLCJones Day is acting as U.S. counsel to Parker Hannifin Corporation in the £6.3 billion acquisition of Meggitt plc, a leading international company headquartered in Coventry, United Kingdom, specializing in high performance components and subsystems for the aerospace, defense and selected energy markets.
  • Axion BioSystems completes sale of company to Summa EquityJones Day advised Axion BioSystems, Inc., a leading provider of MEA and impedance technology for single-cell analysis, in its sale of the company to Summa Equity.
  • U.S. Steel sells Transtar, LLC to Fortress Transportation and Infrastructure Investors for $640 millionJones Day represented United States Steel Corporation, an integrated steel producer with major production operations in the United States and Central Europe, in connection with the sale of its wholly owned short-line railroad subsidiary, Transtar, LLC, to a subsidiary of Fortress Transportation and Infrastructure Investors LLC for $640 million.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • PureCycle Technologies combines with Roth CH Acquisition I Co.Jones Day advised PureCycle Technologies LLC ("PureCycle") in its business combination with Roth CH Acquisition I Co. ("Roth SPAC"), a publicly-traded special purpose acquisition corporation backed by Roth Capital Partners and Craig-Hallum Capital Group, and Roth CH Acquisition I Co. Parent Corp., a wholly owned subsidiary of Roth CH ("Holdings"), among others.
  • DataBank acquires zColo for $1.4 billionJones Day advised DataBank, a leading provider of enterprise-class colocation, connectivity, and managed services, in connection with the acquisition and financing of zColo, including certain U.S. and European data center assets, from Zayo Group Holdings, Inc. for $1.4 billion.
  • STERIS acquires Key Surgical for approximately $850 millionJones Day advised STERIS plc (NYSE: STE) in the $850 million acquisition of Key Surgical, a leading global provider of sterile processing, operating room, and endoscopy products, and a portfolio company of Water Street Healthcare Partners, LLC.
  • UPMC prevails in trial before Commonwealth Court of PennsylvaniaJones Day won a bench trial on behalf of the University of Pittsburgh Medical Center ("UPMC"), one of the nation's preeminent integrated healthcare systems.